Irwin Naturals Inc.

Equities

IWIN

CA46414Q1054

Pharmaceuticals

End-of-day quote Canadian Securities Exchange 06:00:00 2024-04-10 pm EDT 5-day change 1st Jan Change
0.14 USD -31.71% Intraday chart for Irwin Naturals Inc. 0.00% -26.32%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Irwin Naturals, Inc. Announces CFO Changes CI
Irwin Naturals, Inc. Announces Directors Changes CI
Tranche Update on Irwin Naturals, Inc.'s Equity Buyback Plan announced on September 26, 2022. CI
Irwin Naturals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Irwin Naturals, Inc. - Shareholder/Analyst Call
Irwin Naturals, Inc.'s Equity Buyback announced on September 26, 2022, has closed with 81,000 shares, representing 3.74% for CAD 0.21 million. CI
Irwin Naturals Swings to Loss in Q2, Revenue Grows MT
Irwin Naturals Announces Goodwill Impairment for the Second Quarter Ended June 30, 2023 CI
Tranche Update on Irwin Naturals, Inc.'s Equity Buyback Plan announced on September 26, 2022. CI
Irwin Naturals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Irwin Naturals Inc. Announces Licensing and Supply Agreement with The Hive Laboratory, LLC CI
Irwin Naturals, Inc. Appoints Sheri Orlowitz as New Director CI
Irwin Naturals, Inc. Reports Impairment Charges for the First Quarter Ended March 31, 2023 CI
Tranche Update on Irwin Naturals, Inc.'s Equity Buyback Plan announced on September 26, 2022. CI
Irwin Naturals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tranche Update on Irwin Naturals, Inc.'s Equity Buyback Plan announced on September 26, 2022. CI
Irwin Naturals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Irwin Naturals, Inc. Auditor Raises 'Going Concern' Doubt CI
Irwin Naturals Inc. Announces Directorate Changes CI
Irwin Naturals Inc. terminated agreement to acquire Assets of Tri-Cities Infusion & Wellness Clinic, PLLC. CI
Irwin Naturals Launches New Product in Canada MT
Irwin Naturals Brief: Says Cannabis Products Launch Nationwide in Canada MT
Irwin Naturals Inc. Announces the Release of Irwin Naturals Cannabis' New CBD 25mg Softgels in Canada CI
Irwin Naturals Closes Purchase of Ketamine Media MT
Irwin Naturals Inc. completed the acquisition of Keta Media, LLC. CI
Chart Irwin Naturals Inc.
More charts
Irwin Naturals Inc. (Irwin) is a nutraceutical company. The Company is engaged in distributing cannabidiol (CBD) products in mass-market and health food chain stores across the United States. Irwin's portfolio of herbal products is available in more than 100,000 retail doors across North America. The Company's full range of Vitamin, CBD, and Supplements features over 100 products, created to address mood and brain function, better sleep, sports performance, sexual health, immune support, weight management, women's health and men's health. The Company's ketamine clinic, Emergence, is an infusion clinic that offers intravenous (IV) ketamine for the treatment of depression, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), anxiety, bipolar disorder, migraines, and multiple chronic pain conditions such as complex regional pain syndrome (CRPS), reflex sympathetic dystrophy (RSD) and fibromyalgia.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
  1. Stock Market
  2. Equities
  3. IWIN Stock
  4. News Irwin Naturals Inc.
  5. Irwin Naturals : Plans Entry into THC Side of Cannabis Market; Set Up unit for Psychedelic Mental Health Space